ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronEye IconIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailMenu BurgerPositive ArrowIcon PrintIcon SearchSite TitleTitle ChevronIcon Twitter
Health Technology

Sysmex Corp.

  • 7,800.00 JPY
  • +95.00
  • +1.23%
  • Japan
    May 24, 2019
  • Ticker
    TKS(6869)
  • Prev. close
    7,705
  • Market cap (JPY)
    1,611.62B
  • Market cap (USD)
    14,697.20M
  • Shares
    209.16M

Business Summary

Sysmex Corp. engages in the development, manufacture, import, export, and sale of clinical laboratory instruments, reagents, and software used in in-vitro diagnostics. It also provides clinical laboratory testing of blood, urine, and other specimens. Its products include instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing. It operates through the following geographical segments: Japan, Americas, EMEA, China, and Asia Pacific. The company was founded on February 20, 1968 and is headquartered in Kobe, Japan.

Financial Highlights

Mar 2019 JPYUSD
Revenue293,506M2,646.70M
Gross Profit161,607M1,457.30M
Operating income60,799M548.25M
Income before tax57,955M522.61M
Net income41,224M371.74M
EBITDA76,641M691.11M
Diluted EPS197.281.77
Dividends Per Share700.63
Total Assets346,775M3,132.99M
Total liabilities81,590M737.13M
Total equity264,449M2,389.20M
Operating cash flow44,743M403.47M
Currency in JPYCurrency in USD

Historical Data

 Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Revenue 221,376M 252,622M 249,899M 281,935M 293,506M
Gross Profit 122,383M 150,690M 141,777M 158,949M 161,607M
Operating income 44,411M 60,710M 50,822M 59,947M 60,799M
Income before tax 45,727M 57,809M 48,946M 58,117M 57,955M
Net income 26,638M 39,278M 40,635M 39,221M 41,224M
EBITDA 57,364M 72,820M 63,203M 74,590M 76,641M
Diluted EPS 128.02 188.30 194.74 187.84 197.28
Dividends Per Share 38 52 58 66 70
Total Assets 247,983M 263,917M 279,817M 321,979M 346,775M
Total liabilities 78,433M 82,864M 71,248M 80,531M 81,590M
Total equity 169,550M 182,801M 209,407M 240,750M 264,449M
Operating cash flow 38,640M 41,794M 32,832M 52,240M 44,743M
 Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Revenue 2,015.13M 2,103.70M 2,307.73M 2,543.79M 2,646.70M
Gross Profit 1,114.02M 1,254.86M 1,309.26M 1,434.13M 1,457.30M
Operating income 404.26M 505.56M 469.32M 540.87M 548.25M
Income before tax 416.24M 481.40M 452.00M 524.36M 522.61M
Net income 242.47M 327.08M 375.25M 353.87M 371.74M
EBITDA 522.17M 606.40M 583.65M 672.99M 691.11M
Diluted EPS 1.16 1.56 1.79 1.69 1.77
Dividends Per Share 0.34 0.43 0.53 0.59 0.63
Total Assets 2,067.81M 2,348.12M 2,511.14M 3,027.54M 3,132.99M
Total liabilities 654.01M 737.25M 639.39M 757.22M 737.13M
Total equity 1,413.80M 1,626.41M 1,879.26M 2,263.75M 2,389.20M
Operating cash flow 351.73M 348.03M 303.19M 471.34M 403.47M

Valuation Measures

Mar 2019
PER33.85
ROA12.32%
ROE16.31%
Operating margin20.71%
Profit margin14.04%

Key executives

  • Chairman, Chief Executive Officer & President: Hisashi Ietsugu
  • CFO, Director & Senior Managing Executive Officer: Yukio Nakajima
  • Director, CTO & Senior Managing Executive Officer: Kaoru Asano
  • Executive Officer: Keiji Fujimoto
  • Executive Officer: Yukio Hamaguchi

Shareholders

  • Kobe Yamabuki Foundation (5.7%)
  • Nakatani Foundation (5.6%)
  • Nakatani Kosan YK (4.9%)
  • IETSUGU KAZUKO (2.9%)
  • WADA TAEKO (2.9%)
  • The Vanguard Group, Inc. (2.3%)
  • Estate of Tadashi Nakatani (2.2%)
  • ITANI KENJI (2.0%)
  • Harding Loevner LP (1.6%)
  • Wellington Management Co. LLP (1.6%)

Contact Details

  • Website:http://www.sysmex.co.jp
  • Address: 1-5-1 Wakinohama-Kaigandori, Chuo-Ku, Kobe, 651-0073, Japan
  • Phone: +81.78.265.0500

Related Companies

  • Sysmex Medical Electronics (Shanghai) Co., Ltd.
  • Sysmex Wuxi Co. Ltd.
  • Sysmex Inostics, Inc.
  • Sysmex Turkey Diagnostik Sistemleri Ltd. STI
  • Sysmex (Malaysia) Sdn.Bhd.
  • Sysmex Vietnam Co. Ltd.
  • Sysmex Taiwan Co. Ltd.
  • Sysmex Suisse AG
  • Sysmex Slovakia sro
  • Sysmex Shanghai Ltd.
  • Sysmex RUS LLC
  • Sysmex Polska Sp zoo
  • Sysmex Philippines, Inc.
  • Sysmex Hungaria Kft.
  • Sysmex Hong Kong Ltd.
  • Sysmex Espana SL
  • Sysmex do Brasil Industria e Comercio Ltda.
  • Sysmex CZ sro
  • Sysmex Canada, Inc.
  • Sysmex Austria GmbH
  • Sysmex Middle East FZ LLC
  • Sysmex South Africa (Pty) Ltd.
  • Sysmex Inostics GmbH
  • Sysmex Korea Co., Ltd.
  • Katakura Industries Co. Ltd. /Biological Research Center/
  • Sysmex RA Co. Ltd.
  • Sysmex Europe GmbH
  • Sysmex Deutschland GmbH
  • Sysmex TMC Co., Ltd.
  • Sysmex International Reagents Co., Ltd.

Competitors

  • bioMerieux SA
  • Haemonetics Corporation
  • Bio-Techne Corporation
  • Epigenomics AG
  • Biocept, Inc.
  • Guardant Health, Inc.
Last Updated on 24 May, 2019

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Get Unlimited access

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends May 26th

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media